Childress Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $242K | Sell |
5,221
-608
| -10% | -$28.1K | 0.06% | 216 |
|
|
2025
Q1 | $356K | Sell |
5,829
-1,189
| -17% | -$72.5K | 0.1% | 143 |
|
|
2024
Q4 | $397K | Buy |
7,018
+1,051
| +18% | +$59.4K | 0.11% | 127 |
|
|
2024
Q3 | $309K | Buy |
+5,967
| New | +$309K | 0.08% | 164 |
|
|
2024
Q2 | – | Sell |
-4,679
| Closed | -$254K | – | 224 |
|
|
2024
Q1 | $254K | Buy |
+4,679
| New | +$254K | 0.07% | 173 |
|
|
2023
Q4 | – | Sell |
-4,804
| Closed | -$265K | – | 203 |
|
|
2023
Q3 | $265K | Buy |
+4,804
| New | +$265K | 0.09% | 141 |
|
|
2023
Q1 | – | Sell |
-8,210
| Closed | -$591K | – | 100 |
|
|
2022
Q4 | $591K | Buy |
8,210
+365
| +5% | +$26.3K | 0.2% | 75 |
|
|
2022
Q3 | $567K | Sell |
7,845
-886
| -10% | -$64K | 0.22% | 76 |
|
|
2022
Q2 | $672K | Buy |
8,731
+367
| +4% | +$28.2K | 0.27% | 67 |
|
|
2022
Q1 | $612K | Buy |
8,364
+1,833
| +28% | +$134K | 0.21% | 84 |
|
|
2021
Q4 | $407K | Sell |
6,531
-1,351
| -17% | -$84.2K | 0.17% | 106 |
|
|
2021
Q3 | $465K | Buy |
7,882
+1,461
| +23% | +$86.2K | 0.19% | 98 |
|
|
2021
Q2 | $429K | Sell |
6,421
-1,574
| -20% | -$105K | 0.2% | 89 |
|
|
2021
Q1 | $504K | Buy |
7,995
+3,234
| +68% | +$204K | 0.23% | 86 |
|
|
2020
Q4 | $297K | Buy |
+4,761
| New | +$297K | 0.17% | 71 |
|